17 May 2022 : Original article
Tacrolimus-Induced Neurotoxicity in Early Post-Liver Transplant Saudi Patients: Incidence and Risk Factors
Dema A. Alissa1ABCDEF*, Delal Alkortas1AE, Mohammed Alsebayel2AE, Rawan Abdullah Almasuood3EF, Wejdan Aburas
3EF, Tahani Altamimi4F, Edward Bentz Devol 5CD, Ahmed H. Al-jedai 16ADE
DOI: 10.12659/AOT.935938
Ann Transplant 2022; 27:e935938
Table 4 Secondary endpoints for liver transplant recipients who developed ECIIN.
| All patients (n=338) | Patients that developed ECIIN (n=63) | P-value | |
|---|---|---|---|
| 30 day mortality | 8 (2%) | 2 (25%; 7.49–70.07) | 0.3769 |
| Hospital length of stay (days) (median (first quartile-third ruartile)) | 19 (13–31) | 31 (21–75.5) | |
| ICU length of stay (days) (median (first quartile-third ruartile)) | 4 (2–9.75) | 10 (5–20.5) |